Copyright
©The Author(s) 2004.
World J Gastroenterol. Mar 1, 2004; 10(5): 649-653
Published online Mar 1, 2004. doi: 10.3748/wjg.v10.i5.649
Published online Mar 1, 2004. doi: 10.3748/wjg.v10.i5.649
Table 4 Hepatocellular carcinoma stage and survival time, Okuda stage and survival time
Group | Stage | MSD | |||
I | II | III | |||
A (n = 19) | Case No. | 5 | 9 | 5 | |
Survival days | 161 | 26.8 | 10.5 | 25.2 | |
B (n = 76) | Case No. | 19 | 41 | 16 | |
Survival days | 171.5 | 136.5 | 47.3 | 108.5 |
- Citation: Wang TE, Kao CR, Lin SC, Chang WH, Chu CH, Lin J, Hsieh RK. Salvage therapy for hepatocellular carcinoma with thalidomide. World J Gastroenterol 2004; 10(5): 649-653
- URL: https://www.wjgnet.com/1007-9327/full/v10/i5/649.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i5.649